Quantum Skinsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 82 days for 2021).
- 2025not filed
- 202416/05/2025
- 202303/07/2024
- 202221/08/2023
- 202105/10/2022
- 202008/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Quantum Origin Inc. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-04-12.
79 1090 1362 0000 0001 4230 2513
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $3,190,067.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 10, 2020 | Aid for research and development projects: industrial research | $2.6M$2,588,975 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 10, 2020 | Aid for research and development projects: experimental development | $422.8K$422,850 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 10, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $113.1K$113,135 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-04-01 | Research and development on an innovative method for personalized selection and application of cosmeceuticals and development of a new range of cosmeceuticals for application using a mobile dermatological microparticle-spraying applicator | $3.1M$3,107,375 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Laboratorium Badawcze Sorbolabsp. z o.o. | $1,593,152.63 | sorbolab.pl | ||
| Centrum Alergologiisp. z o.o. | $812,503.07 | centrumalergologii.pl | ||
| Reumedikasp. z o.o. | $323,427.61 | reumedika.pl | ||
| Wielkopolskie Centrum Medycyny Podróżysp. z o.o. | $175,243.92 | medtrop.pl | ||
| Green Cenergysp. z o.o. | $47,243.84 | greencenergy.pl | ||
| EmpekoS.A. | $13,339.66 | empeko.pl | ||
| Biuro Studiów Inżynierskich Resolv3d Poznańsp. z o.o. | $3,223.34 | resolv3d.pl | ||
| Klause&StaschS.A. | $2,988.76 | klausestasch.kmpsa.net.pl | ||
| Optiliosp. z o.o. | $2,789.21 | optil.io | ||
| Empyriosp. z o.o. | $753.70 | empyrio.com |
FAQ
Last updated: 2026-10-07